Target intelligence / Profile preview

Arterial wall and plaque

Molecular classification
Other
01

Overview

The arterial wall is a specialized, multi-layered tissue structure composed of the intima, media, and adventitia, which functions to regulate hemodynamics and maintain vascular health (Source: StatPearls, 'Physiology, Blood Pressure'). An atherosclerotic plaque is a focal pathological lesion within the arterial wall characterized by the accumulation of cholesterol, fibrous elements, and inflammatory cells such as macrophages (Source: NIH, 'Atherosclerosis'). While 'Arterial wall and plaque' is an anatomical and pathological site rather than a single molecular target, it is the central focus of intervention for cardiovascular diseases. Therapeutic strategies, including the use of statins and PCSK9 inhibitors, aim to modify the plaque's composition to reduce the lipid-rich necrotic core and strengthen the fibrous cap (Source: Nature Reviews Cardiology, 'Plaque stabilization'). This process, known as plaque stabilization, is critical for preventing clinical events such as myocardial infarction and stroke caused by plaque rupture and subsequent thrombosis.

Other names
Atherosclerotic plaqueAtheromaVascular wallArterial intimaVulnerable plaque
02

Mechanism of action

Drugs targeting the arterial wall and plaque typically function by lowering systemic lipid levels, reducing vascular inflammation, inhibiting platelet aggregation, or stabilizing the fibrous cap to prevent lesion rupture (Source: Nature Reviews Cardiology, 'Plaque stabilization').

03

Biological functions

Vascular homeostasisBlood pressure regulationStructural supportLipid metabolismImmune response
04

Disease associations

Cardiovascular diseaseAtherosclerosisCoronary artery diseasePeripheral artery diseaseStrokeMyocardial infarction
05

Safety considerations

Plaque ruptureIntra-plaque hemorrhageArterial calcificationMyopathy (associated with lipid-lowering agents)Increased bleeding risk (associated with antiplatelet therapy)
06

Interacting drugs

Atorvastatin

7 more in the full profile.

07

Biomarkers

Low-density lipoprotein cholesterol (LDL-C)High-sensitivity C-reactive protein (hs-CRP)Intima-media thickness (IMT)Coronary artery calcium (CAC) scoreLipoprotein(a)

Beyond the preview

Go deeper on Arterial wall and plaque.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arterial wall and plaque.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call